Small account play with potential upcoming COVID catalyst
Uppdaterad
Vaccine play: “Four vaccine candidates developed from VXRT's proprietary VAAST platform were assessed in mouse models and elicited a strong immune response.” (finance.yahoo.com/news/advantage-vaxart-sharp-pullback-says-200653838.html)
Fib targets above, can use 0 fib below for stop loss.
- Potential upcoming catalyst of a Phase 1 trial
As of last week, down 73% since the yearly high, has begun to reverse.
Very oversold on SlowStoch and has been for nearly a month
Below 100day SMA, only slightly above 200day SMA
Fib targets above, can use 0 fib below for stop loss.
Trade stängt: målet nått
Even as a late add this was a big winner.Handel aktiv
Re-entered, but chasing slightly. Hoping for a break to 9.47 and above.
Frånsägelse av ansvar
Informationen och publikationerna är inte avsedda att vara, och utgör inte heller finansiella, investerings-, handels- eller andra typer av råd eller rekommendationer som tillhandahålls eller stöds av TradingView. Läs mer i Användarvillkoren.